The FDA's Schedule I label on cannabis is the single biggest barrier holding medical marijuana stocks back.

That barrier could be coming down soon, and you'll want to own shares of GW Pharmaceuticals when it does.

Lo and behold – a bill is moving through the U.S.

Senate to do just this.